SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation Patients Hospitalized at Neuroscience Hospital in Italy.
作者信息
Di Gennaro Francesco, Marotta Claudia, Storto Marianna, D'Avanzo Carmine, Foschini Nunzia, Maffei Luigi, de Gaetano Giovanni, Centonze Diego, Iezzi Ennio
机构信息
IRCCS Istituto Neurologico Mediterraneo NEUROMED, 86077 Pozzilli, Italy.
Unit of Neurology and Neurorehabilitation, IRCCS Neuromed, Pozzilli (IS), Italy.
出版信息
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020063. doi: 10.4084/MJHID.2020.063. eCollection 2020.
Abstract
摘要
相似文献
1
SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation Patients Hospitalized at Neuroscience Hospital in Italy.
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020063. doi: 10.4084/MJHID.2020.063. eCollection 2020.
2
Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.
Neurol Res Pract. 2021 Mar 12;3(1):17. doi: 10.1186/s42466-021-00116-1.
3
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
Neurol Neuroimmunol Neuroinflamm. 2022 Mar 7;9(3). doi: 10.1212/NXI.0000000000001151. Print 2022 May.
4
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
5
Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study.
EClinicalMedicine. 2020 Oct 5;27:100562. doi: 10.1016/j.eclinm.2020.100562. eCollection 2020 Oct.
6
Enoxaparin Use in Hospitalized SARS-CoV-2-Positive Patients with Elevated D-Dimer: A Pilot Study.
J Pharm Pract. 2023 Jun;36(3):532-536. doi: 10.1177/08971900211064184. Epub 2021 Dec 24.
7
[Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
Ideggyogy Sz. 2020 May 30;73(05-06):171-175. doi: 10.18071/isz.73.0171.
8
SARS-CoV-2 Infection in Children in Southern Italy: A Descriptive Case Series.
Int J Environ Res Public Health. 2020 Aug 21;17(17):6080. doi: 10.3390/ijerph17176080.
9
Clinical course of SARS-CoV-2 infection in patients with severe acquired brain injury and a disorder of consciousness: an observational study.
Brain Inj. 2021 Apr 16;35(5):520-529. doi: 10.1080/02699052.2021.1887937. Epub 2021 Feb 15.
10
Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey.
JMIR Public Health Surveill. 2020 Sep 18;6(3):e21866. doi: 10.2196/21866.
引用本文的文献
1
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.
Int J Mol Sci. 2023 May 18;24(10):8945. doi: 10.3390/ijms24108945.
2
The Outcomes of COVID-19 Patients with Spontaneous Intracerebral Hemorrhage Comorbidity and the Efficacy of Enoxaparin in Decreasing the Mortality Rate in Them: Single Egyptian Center Report.
J Pers Med. 2022 Nov 2;12(11):1822. doi: 10.3390/jpm12111822.
3
New endemic and pandemic pathologies with interhuman airborne transmission through ear, nose and throat anatomical sites.
Acta Otorhinolaryngol Ital. 2022 Apr;42(Suppl. 1):S5-S13. doi: 10.14639/0392-100X-suppl.1-42-2022-01.
4
Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations.
Infect Dis Ther. 2021 Dec;10(4):1907-1931. doi: 10.1007/s40121-021-00500-z. Epub 2021 Jul 22.
5
Epidemiology, Clinical Characteristics, and Outcomes of a Large Cohort of COVID-19 Outpatients in Michigan.
Int J Gen Med. 2021 Apr 28;14:1555-1563. doi: 10.2147/IJGM.S305295. eCollection 2021.
6
First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain.
PLoS One. 2021 Mar 31;16(3):e0248029. doi: 10.1371/journal.pone.0248029. eCollection 2021.
本文引用的文献
1
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01987-20.
2
Spontaneous and Severe Haematomas in Patients with COVID-19 on Low- Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation.
Mediterr J Hematol Infect Dis. 2020 Jul 1;12(1):e2020054. doi: 10.4084/MJHID.2020.054. eCollection 2020.
3
Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review.
Int J Environ Res Public Health. 2020 Apr 14;17(8):2690. doi: 10.3390/ijerph17082690.
4
[Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 28;41(0):E006. doi: 10.3760/cma.j.issn.0253-2727.2020.0006.
5
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
6
Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020.
Clin Chim Acta. 2020 Jun;505:172-175. doi: 10.1016/j.cca.2020.03.009. Epub 2020 Mar 7.
7
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.
Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.
8
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.
Radiology. 2020 Aug;296(2):E32-E40. doi: 10.1148/radiol.2020200642. Epub 2020 Feb 26.
9
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
10
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
Zotero 插件